Cytogen, Inc. (KOSDAQ:217330)
South Korea flag South Korea · Delayed Price · Currency is KRW
4,640.00
-235.00 (-4.82%)
At close: Mar 6, 2026

Cytogen Market Cap

Cytogen has a market cap or net worth of 107.04 billion as of March 6, 2026. Its market cap has increased by 5.94% in one year.

Market Cap
107.04B
Enterprise Value
89.95B
Revenue
25.09B
Ranking
n/a
PE Ratio
n/a
Stock Price
4,640.00

Market Cap Chart

Since November 22, 2018, Cytogen's market cap has increased from 87.89B to 107.04B, an increase of 21.79%. That is a compound annual growth rate of 2.74%.

History

DateMarket Cap% Change
Mar 6, 2026107.04B-48.39%
Dec 30, 2025207.40B98.24%
Dec 30, 2024104.62B-59.34%
Dec 28, 2023257.28B-11.12%
Dec 29, 2022289.47B-18.62%
Dec 30, 2021355.72B47.87%
Dec 30, 2020 Pro Pro
Dec 30, 2019 Pro Pro
Dec 28, 2018 Pro Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
HLB Panagene 92.99B
GENINUS 140.91B
Green Cross Medical Science 79.03B
Protia 63.87B
Seoulin Bioscience 56.23B
GeneMatrix 45.27B
Dx & Vx 401.10B
3billion 451.33B
Market Cap Rankings